Literature DB >> 14752826

Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells.

Jinah Choi1, Ki Jeong Lee, Yanyan Zheng, Ardath K Yamaga, Michael M C Lai, Jing-Hsiung Ou.   

Abstract

Hepatitis C virus (HCV) is a positive-stranded RNA virus that causes severe liver diseases, such as cirrhosis and hepatocellular carcinoma. HCV uses an RNA-dependent RNA polymerase to replicate its genome and an internal ribosomal entry site to translate its proteins. HCV infection is characterized by an increase in the concentrations of reactive oxygen species (ROS), the effect of which on HCV replication has yet to be determined. In this report, we investigated the effect of ROS on HCV replication, using a bicistronic subgenomic RNA replicon and a genomic RNA that can replicate in human hepatoma cells. The treatment with peroxide at concentrations that did not deplete intracellular glutathione or induce cell death resulted in significant decreases in the HCV RNA level in the cells. This response could be partially reversed by the antioxidant N-acetylcysteine. Further studies indicated that such a suppressive response to ROS was not due to the suppression of HCV protein synthesis or the destabilization of HCV RNA. Rather, it occurred rapidly at the level of RNA replication. ROS appeared to disrupt active HCV replication complexes, as they reduced the amount of NS3 and NS5A in the subcellular fraction where active HCV RNA replication complexes were found. In conclusion, our results show that ROS can rapidly inhibit HCV RNA replication in human hepatoma cells. The increased ROS levels in hepatitis C patients may therefore play an important role in the suppression of HCV replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752826     DOI: 10.1002/hep.20001

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  63 in total

Review 1.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

2.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 3.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

4.  Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.

Authors:  David Widjaja; Suresh Yarlagadda; Bheema S Singu; Raghu S Loganathan; Steve Blum; Alan Bloom; Prospere Remy
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

5.  Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.

Authors:  A Abdel Moneim; H A Suleiman; B Mahmoud; D Mabrouk; M Y Zaky; B Mahmoud
Journal:  Clin Exp Med       Date:  2020-02-19       Impact factor: 3.984

Review 6.  Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Authors:  Pierre Nahon; Angela Sutton; Marianne Ziol; Jessica Zucman-Rossi; Jean-Claude Trinchet; Nathalie Ganne-Carrié
Journal:  Hepat Oncol       Date:  2015-01-12

7.  Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative.

Authors:  Wataru Ito; Masaaki Toyama; Mika Okamoto; Masanori Ikeda; Koichi Watashi; Takaji Wakita; Yuichi Hashimoto; Masanori Baba
Journal:  Antivir Chem Chemother       Date:  2016-08-19

8.  Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication.

Authors:  Gulam Waris; Aleem Siddiqui
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

9.  Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication.

Authors:  Rongjuan Dai; Xinqiang Xiao; Feng Peng; Mingming Li; Guozhong Gong
Journal:  Virus Genes       Date:  2016-01-06       Impact factor: 2.332

10.  Increased ATP generation in the host cell is required for efficient vaccinia virus production.

Authors:  Chia-Wei Chang; Hui-Chun Li; Che-Fang Hsu; Chiao-Yen Chang; Shih-Yen Lo
Journal:  J Biomed Sci       Date:  2009-09-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.